DK480184A - Fremgangsmaade til pasteurisering af plasma eller af koncentrater af blodkoaguleringsfaktorerne ii, vii, ix og x - Google Patents

Fremgangsmaade til pasteurisering af plasma eller af koncentrater af blodkoaguleringsfaktorerne ii, vii, ix og x Download PDF

Info

Publication number
DK480184A
DK480184A DK480184A DK480184A DK480184A DK 480184 A DK480184 A DK 480184A DK 480184 A DK480184 A DK 480184A DK 480184 A DK480184 A DK 480184A DK 480184 A DK480184 A DK 480184A
Authority
DK
Denmark
Prior art keywords
vii
blood coagulation
coagulation factors
pasteurization
concentrates
Prior art date
Application number
DK480184A
Other languages
English (en)
Other versions
DK480184D0 (da
DK167598B1 (da
Inventor
Norbert Heimburger
Gerhardt Kumpe
Wilfried Wormsbaecher
Hans Martin Preis
Original Assignee
Behringwerke Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke Ag filed Critical Behringwerke Ag
Publication of DK480184D0 publication Critical patent/DK480184D0/da
Publication of DK480184A publication Critical patent/DK480184A/da
Application granted granted Critical
Publication of DK167598B1 publication Critical patent/DK167598B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
    • A61L2/0023—Heat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/02—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
    • A61L2/04—Heat

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
DK480184A 1983-10-08 1984-10-05 Fremgangsmaade til pasteurisering af plasma eller af koncentrater af blodkoaguleringsfaktorerne ii, vii, ix og x DK167598B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3336631 1983-10-08
DE19833336631 DE3336631A1 (de) 1983-10-08 1983-10-08 Verfahren zur pasteurisierung von plasma oder von konzentraten der blutgerinnungsfaktoren ii, vii, ix und x

Publications (3)

Publication Number Publication Date
DK480184D0 DK480184D0 (da) 1984-10-05
DK480184A true DK480184A (da) 1985-04-09
DK167598B1 DK167598B1 (da) 1993-11-29

Family

ID=6211328

Family Applications (1)

Application Number Title Priority Date Filing Date
DK480184A DK167598B1 (da) 1983-10-08 1984-10-05 Fremgangsmaade til pasteurisering af plasma eller af koncentrater af blodkoaguleringsfaktorerne ii, vii, ix og x

Country Status (14)

Country Link
US (1) US6346277B1 (da)
EP (1) EP0137428B1 (da)
AT (1) ATE42899T1 (da)
AU (1) AU590191B2 (da)
CA (1) CA1246444A (da)
DE (2) DE3336631A1 (da)
DK (1) DK167598B1 (da)
ES (1) ES8605677A1 (da)
FI (1) FI81363C (da)
IL (1) IL73189A (da)
MX (1) MX167398B (da)
NZ (1) NZ209784A (da)
PT (1) PT79318B (da)
ZA (1) ZA847823B (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3602688A1 (de) * 1986-01-30 1987-08-06 Behringwerke Ag Verfahren zur gewinnung und herstellung eines pasteurisierten praeparates von (alpha)(pfeil abwaerts)2(pfeil abwaerts)-antiplasmin
DE3877529T2 (de) * 1987-10-23 1996-11-07 Centre Regional De Transfusion Herstellung von hoch-gereingtem menschlichen Faktor IX sowie anderem Plasmaproteinkonzentrat und dessen therapeutische Verwendung.
FR2631830B1 (fr) * 1988-05-25 1991-06-21 Lille Transfusion Sanguine Concentre de facteur ix de haute purete, sa preparation et son utilisation en therapeutique
DK18288D0 (da) * 1988-01-15 1988-01-15 Nordisk Gentofte Fremgangsmaade til pasteurisering af vandige oploesninger af faktor viii
DE3938907C2 (de) * 1989-11-24 1999-11-04 Dade Behring Marburg Gmbh Mittel zum Lagern und Suspendieren von Zellen, insbesondere Erythrozyten
DE4001451A1 (de) * 1990-01-19 1991-08-01 Octapharma Ag Stabile injizierbare loesungen von faktor viii und faktor ix
FR2664165B1 (fr) * 1990-07-03 1992-10-16 Lille Transfusion Sanguine Composition pour stabiliser le plasma sanguin en cours de pasteurisation.
DK2193809T3 (da) 1999-02-22 2015-05-26 Univ Connecticut Albumin-frie faktor-VIII-formuleringer
US6245548B1 (en) * 2000-03-09 2001-06-12 American National Red Cross Activation of pure prothrombin to thrombin with about 30% to about 40% sodium citrate
GB0216002D0 (en) * 2002-07-10 2002-08-21 Nat Blood Authority Process and composition
DE20218363U1 (de) * 2002-11-26 2004-01-15 Meltem Wärmerückgewinnung GmbH & Co. KG Luftaustauschsystem für die Entlüftung wenigstens eines Raums eines Gebäudes
US20040229778A1 (en) * 2003-05-13 2004-11-18 Elmaleh David R. Pharmaceutical compositions of antithrombin III for the treatment of retroviral diseases
MX339060B (es) 2008-11-07 2016-05-09 Baxter Int Formulaciones del factor viii.
KR102658958B1 (ko) 2017-02-09 2024-04-22 체에스엘 베링 게엠베하 출혈의 치료 또는 예방에 사용하기 위한 혈액 응고 인자 대체품

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4364861A (en) * 1980-05-27 1982-12-21 Cutter Laboratories, Inc. Blood-coagulation-promoting products and methods of preparing them
US4391746A (en) * 1980-05-27 1983-07-05 Cutter Laboratories, Inc. Blood-coagulation-promoting products and methods of preparing them
EP0050061B2 (en) * 1980-10-06 1990-06-20 New York Blood Center, Inc. Method of reducing undesirable activities of biological and pharmaceutical products
US4315919A (en) 1980-10-06 1982-02-16 Edward Shanbrom Depyrogenation process
US4314997A (en) 1980-10-06 1982-02-09 Edward Shanbrom Purification of plasma protein products
US4412985A (en) 1980-10-06 1983-11-01 Edward Shanbrom Depyrogenation process
DE3043857A1 (de) * 1980-11-21 1982-07-08 Behringwerke Ag, 3550 Marburg Verfahren zur herstellung von blutgerinnungsfaktoren und danach hergestellte praeparation der faktoren ii und vii
DE3045153A1 (de) * 1980-11-29 1982-07-08 Behringwerke Ag, 3550 Marburg Verfahren zur herstellung von blutgerinnungsfaktoren und danach hergestellte praeparation der faktoren ix und x
DE3230849A1 (de) * 1982-08-19 1984-02-23 Behringwerke Ag, 3550 Marburg Pasteurisiertes human-fibrinogen (hf) und verfahren zu dessen herstellung
DE3237512A1 (de) 1982-10-09 1984-04-12 Behringwerke Ag, 3550 Marburg Verfahren zur pasteurisierung von antihaemophilem kryopraezipitat (ahk) und danach hergestelltes antihaemophiles kryopraezipitat
FR2681867B1 (fr) * 1991-09-26 1993-12-31 Pasteur Merieux Serums Vaccins Procede de purification du facteur viii et preparations obtenues.
IT1262899B (it) * 1992-03-27 1996-07-22 Sclavo Spa Processo per l'isolamento di fattore ix, fattore x e fattore ii altamente purificati dal complesso protrombinico o dal plasma umano

Also Published As

Publication number Publication date
EP0137428B1 (de) 1989-05-10
US6346277B1 (en) 2002-02-12
DK480184D0 (da) 1984-10-05
NZ209784A (en) 1987-10-30
FI843909A0 (fi) 1984-10-04
FI81363B (fi) 1990-06-29
FI81363C (fi) 1990-10-10
FI843909L (fi) 1985-04-09
IL73189A0 (en) 1985-01-31
DE3336631A1 (de) 1985-04-18
AU3388284A (en) 1985-04-18
PT79318B (de) 1986-10-20
DK167598B1 (da) 1993-11-29
AU590191B2 (en) 1989-11-02
ES536549A0 (es) 1985-12-16
DE3478087D1 (en) 1989-06-15
ES8605677A1 (es) 1985-12-16
CA1246444A (en) 1988-12-13
MX167398B (es) 1993-03-22
ZA847823B (en) 1985-05-29
ATE42899T1 (de) 1989-05-15
PT79318A (de) 1984-11-01
EP0137428A2 (de) 1985-04-17
EP0137428A3 (en) 1985-08-07
IL73189A (en) 1988-06-30

Similar Documents

Publication Publication Date Title
DK480184D0 (da) Fremgangsmaade til pasteurisering af plasma eller af koncentrater af blodkoaguleringsfaktorerne ii, vii, ix og x
EP0306778A3 (en) Process for sterilizing plasma or plasma fractions
DE3770576D1 (de) Vorrichtung zur behandlung von blut im extrakorporalen kreislauf.
ES524992A0 (es) Procedimiento para higienizar o pasterizar fribrinogeno humano
ATE40646T1 (de) Verfahren zur pasteurisierung von antihaemophilem kryopraezipitat (ahk) und danach hergestelltes antihaemophiles kryopraezipitat.
DK406184D0 (da) Fremgangsmaade til pasteurisering af humanplasma
DK241684A (da) Fremgangsmaade til fremstilling af et antithrombin iii-heparin- eller antithrombin iii-heparinoidkoncentrat
DK0543178T3 (da) Fremgangsmåde til fremstilling af et virusfrit thrombinkoncentrat
ATE56149T1 (de) Verfahren zum pasteurisieren von fibronectin.
AU7408787A (en) A process for the preparation of a pasteurized immunoglobulin preparation
ATE135238T1 (de) Zusammensetzung zur stabilisierung von blutplasma im laufe der pasteurisation
DK397084A (da) Metronidazolpartikler, steril, praktisk taget neutral, vandig, injicerbar oploesning deraf og pakning til tilberedning

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed

Country of ref document: DK